Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.98 |
| ▸ | THRB | P10828 | 4/20 | 0.98 |
| ▸ | RECQL | P46063 | 4/20 | 0.98 |
| ▸ | BLM | P54132 | 4/20 | 0.98 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.98 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.98 |
| ▸ | PARG | Q86W56 | 2/20 | 0.98 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.98 |
| ▸ | LMNA | P02545 | 1/20 | 0.98 |
| ▸ | MAPT | P10636 | 1/20 | 0.98 |
| ▸ | HPGD | P15428 | 1/20 | 0.98 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.98 |
| ▸ | BLVRB | P30043 | 1/20 | 0.53 |
| ▸ | TDP2 | O95551 | 1/20 | 0.45 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.45 |
| ▸ | GRK2 | P25098 | 1/20 | 0.45 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.45 |
| ▸ | TST | Q16762 | 1/20 | 0.45 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.45 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Rose Bengal Free Acid SCHEMBL29352253 | 0.99 | MEN1 (1.00) | MEN1THRBRECQLBLMKMT2A | |
| Rose Bengal Free Acid SCHEMBL1464825 | 0.99 | MEN1 (1.00) | MEN1THRBRECQLBLMKMT2A | |
| Rose Bengal Free Acid SCHEMBL1444588 | 0.98 | MEN1 (0.98) | MEN1THRBRECQLBLMKMT2A | |
| Rose Bengal Free Acid SCHEMBL16295175 | 0.98 | MEN1 (0.98) | MEN1THRBRECQLBLMKMT2A | |
| SCHEMBL1464215 | 0.94 | MEN1 (0.90) | MEN1THRBRECQLBLMKMT2A | |
| SCHEMBL1444877 | 0.93 | MEN1 (0.88) | MEN1THRBRECQLBLMKMT2A | |
| SCHEMBL1444918 | 0.92 | MEN1 (0.86) | MEN1THRBRECQLBLMKMT2A | |
| SCHEMBL1444592 | 0.92 | MEN1 (0.86) | MEN1THRBRECQLBLMKMT2A | |
| SCHEMBL23423520 | 0.91 | PARG (0.85) | MEN1THRBRECQLBLMKMT2A | |
| SCHEMBL13925140 | 0.91 | PARG (0.85) | MEN1THRBRECQLBLMKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9422260-B2 | Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one(Rose Bengal) and related xanthenes | PROVECTUS PHARMATECH, INC. (US) | 2016-08-23 | — | — | US | disclosed |
| US-9273022-B2 | Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′, 4′, 5′7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one (Rose Bengal) and related xanthenes | PROVECTUS PHARMACEUTICALS, INC. (US) | 2016-03-01 | — | — | US | disclosed |
| EP-2464225-B1 | PROCESS FOR THE SYNTHESIS OF 4,5,6,7-TETRACHLORO-3',6'-DIHYDROXY-2',4',5'7'-TETRAIODO-3H-SPIRO[ISOBENZOFURAN-1,9'-XANTHEN]-3-ONE (ROSE BENGAL) AND RELATED XANTHENES | PROVECTUS PHARMATECH INC (US) | 2015-09-16 | — | — | EP | disclosed |
| US-20140343296-A1 | Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one (Rose Bengal) and Related Xanthenes | TIMOTHY WILLIAMS REVOCABLE TRUST | 2014-11-20 | — | — | US | disclosed |
| US-20130274322-A1 | Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one(Rose Bengal) and Related Xanthenes | PROVECTUS PHARMACEUTICALS, INC. | 2013-10-17 | — | — | US | disclosed |
| US-8530675-B2 | Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one (rose bengal) and related xanthenes | PROVECTUS PHARMACEUTICALS, INC. (US) | 2013-09-10 | — | — | US | disclosed |
| EP-2464225-A1 | PROCESS FOR THE SYNTHESIS OF 4,5,6,7-TETRACHLORO-3',6'-DIHYDROXY-2',4',5'7'-TETRAIODO-3H-SPIRO[ISOBENZOFURAN-1,9'-XANTHEN]-3-ONE (ROSE BENGAL) AND RELATED XANTHENES | Provectus Pharmatech, Inc. (US) | 2012-06-20 | — | — | EP | disclosed |
| US-20110071217-A1 | Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one (Rose Bengal) and Related Xanthenes | PROVECTUS PHARMACEUTICALS, INC. | 2011-03-24 | — | — | US | disclosed |
| WO-2011035161-A1 | PROCESS FOR THE SYNTHESIS OF 4,5,6,7-TETRACHLORO-3',6'-DIHYDROXY-2',4',5'7'-TETRAIODO-3H-SPIRO[ISOBENZOFURAN-1,9'-XANTHEN]-3-ONE (ROSE BENGAL) AND RELATED XANTHENES | PROVECTUS PHARMACEUTICALS, INC. (US) | 2011-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071217-A1 | Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one (Rose Bengal) and Related Xanthenes | TPO, MPO, NISCH | MEN1 1562/4885THRB 184/4885RECQL 1624/4885 |
| US-20140343296-A1 | Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one (Rose Bengal) and Related Xanthenes | TPO, MPO, NISCH | MEN1 1562/4885THRB 184/4885RECQL 1624/4885 |
| US-20130274322-A1 | Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one(Rose Bengal) and Related Xanthenes | TPO, MPO, NISCH | MEN1 1562/4885THRB 184/4885RECQL 1624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.